Approximately 5–20% of Wilms' Tumors cases exhibit somatic WT1 gene mutations which tend to be sporadic bi-allelic aberrations occurring in blastemal progenitors (Kaneko et al., 2015). The gene discussed is WT1; the disease is Nephroblastoma.